
Cancer-SOLES
Cancer-SOLES is a new digital platform for the systematic and continuous preparation of...

Swiss 3Rs Day 2024 – Photos

Swiss 3Rs Day 2025 – Photos

3Rs PROJECT GRANTS
This will be our main call for project funding, now every-other year. Open to academic researchers based in Switzerland aiming for significant 3Rs advancement. This effectively replaces the previous “Open Call” and “Targeted Call” schemes, and is setup to provide increased funding per call.

Using 3D printed mouse tail for IV injection training
Dr. Felix Gantenbein takes us through using a 3D printed tail to practice IV injections for mice.

Refinement Grants
Advancing responsibility: Reducing Surplus Animals and Promoting Change

Gentle Handling Report 2025
In 2020 and 2024, the Swiss 3RCC and the Swiss Culture of Care Network carried out two surveys on the use of non-aversive mouse handling methods among animal care and research staff in Switzerland. Here are the results from the surveys.

3Rs Awards 2024
The Swiss 3R Competence Centre (3RCC) honours the Award winners: Fides Zenk, Doris Zauchner & Manon Murdeu for groundbreaking, human-relevant research replacing and reducing animal use in science.

3Rs EXPLAINER: Animal use in the development of medicine
The development of new treatments for diseases is difficult – it takes time, collaboration and when there are signs that a certain treatment could be effective, experimentation using animals.

FRONTIERS YOUNG MINDS: Introducing the 3Rs to young minds
Enjoy highlights from an engagement event where students from the International School of Lausanne met scientific authors, educating them about the 3R principle of animal experiments: replacement, reduction, and refinement.

TEACH THE TEACHER: Introduction to the 3Rs and the work of the JRC educational activities
This video is the presentation of the educational activities of the workshop by Marcelle Holloway, JRC (European Commission).

TEACH THE TEACHER: Animal use in research and the 3Rs
This video is the 3RCC perspective from the Teacher Training workshop presented by Dr. Jenny Sandström, Executive Director of the Swiss 3RCC (CH).

TEACH THE TEACHER: How to teach Replacement, Reduction and Refinement 3Rs of Animal Use in Science – Introduction
This video is the introduction to the Teach the Teacher workshop given by Dr. David Pamies, UniL (CH).

3Rs DOCTORATE PROGRAMME
The Swiss 3R Competence Centre announces its 2025 3Rs Doctorate Grant scheme, supporting innovative PhD research that advances the replacement, reduction, and refinement of animal use in scientific procedures. This competitive grant scheme follows a two-stage application process and aims to develop a new generation of researchers with strong 3Rs principles.

KNOWLEDGE TRANSFER GRANT
One of the challenges facing the implementation of 3Rs approaches is often the initial...

Inside the lab: fundamentals of cell culture
A collection of videos and standard operating procedures (SOPs) providing clear guidance on...

Annual Report 2024
As 2024 marks the close of the 3RCC’s second federal funding period, we reflect on a phase of notable progress across our core mandates.

PUBLICATION: Refining Research to Improve the Lives of Laboratory Mice
An important discussion in today’s society is whether we should make animals suffer for the sake...

PUBLICATION: Reducing the Number of Research Animals: How Imaging Technologies Can Help
Even when no other alternatives are available for scientific experiments, the use of research...

3Rs Info Hub
The 3Rs InfoHub guides you toward the best approaches intended to replace, reduce or refine animal...

Cellosaurus
The Cellosaurus (https://www.cellosaurus.org/) is a knowledge resource on cell lines. It attempts...
Bringing Story to the 3Rs
The December 2023 ECRN event, "Bringing Story to the 3Rs," brought together a dynamic...

The Art of Presenting with Confidence with Amy Carroll
In this one-day workshop in Bern we welcomed Amy Carroll of Carroll Communications. Amy led 12...

3Rs Hackathon 2024
In this one-day on-site workshop we brought together researcher from varynig fields...

3Rs for Young Minds!
Young people are the next generation of scientists, decision-makers and (hopefully) informed citizens. Helping them understand the 3Rs of animal use in research empowers them to think critically about science, ethics and innovation.

Replacing mice with 3D printed mouse tails for tail injection training
Felix Gantenbein demonstrates how innovation and collaboration come together to reduce the number of mice needed for tail injection training.
An in vitro metastatic niche model of brain metastasis
The home lab (Rubin Lab, DBMR; University of Bern) focuses on in vitro models to investigate lineage plasticity and metastasis and has most recently developed a novel organoid-based model to examine tumour-host interactions and the metastatic niche utilising spatially resolved cerebral organoids.

Generation of vascularized liver spheroid on-chip model for in-vitro infectious disease studies
Our lab develops organs-on-chip (OOC) models, focusing on the lungs, liver and gut. We are creating vascularized tissues-on-chip (patent filed) that better mimic the tissue microenvironment, enabling interaction studies between the vascular systems and their surroundings.

Development, validation, and establishment of intestinal organoids to study host-parasite interactions in veterinary medicine
At my home lab I developed an air-liquid-interface in-vitro model of the red fox (Vulpes vulpes) respiratory tract to study host-parasite interactions in canids. This model is crucial for understanding the pathogenesis and immune responses in canid lungworm infections and can be extended to study further infectious pathogens, given that foxes are reservoirs for many infective agents. Our model is used for studies on the tissue-specific response to lungworm infections using transcriptomic and proteomic approaches.
Moving towards Personalized Medicine: Precision Cut Skin Slices to Model Gene-Responsive Signatures for Novel and Existing Therapies for Systemic Sclerosis Patients
The Centre of Experimental Rheumatology specializes in the investigation of rheumatic and skeletal disorders, including systemic sclerosis (SSc). SSc is a paradigm fibrotic disease characterized by multi-organ fibrosis, including the skin. Currently, tools to investigate SSc pathogenesis include traditional two-dimensional (2D) cell culture and animal models, both of which are established at our institute.
Algorithmic Breeding Planning

An automated system for the assessment of pain and wellbeing in laboratory mice
Monitoring the well-being of mice in research labs is often overlooked, and current methods rely on subjective observations, leading to potential biases and variations between different observers. Recent advancements in machine vision and learning tools offer a solution by automating and standardizing these measures. This project aims to create an all-in-one automated platform (both hardware and software) for monitoring animal welfare.

Evaluation of environmental enrichments for mice
High-quality environmental enrichment ameliorates the quality of life of laboratory mice. Commercially validated enrichment should still be evaluated in house.

Providing immunocompetence to human microtissue bladder models
At my home lab, we established several human bladder microtissue models to understand host-uropathogen interactions in patient-like scenarios, to be tested for novel urinary tract infections (UTI) therapeutics. However, they still lack the immune cell component, which is a crucial need for the field and a main expertise of the group of Dr. Molly Ingersoll (host).

Implementation of the liver fibrosis AOP in a novel liver chip
Our research group aims to implement various biological questions and models in microphysiological systems (MPS). We have established an iPSC-derived blood-brain barrier on a Mimetas chip (Burgio et al., 2023) and an in vitro kidney model on the Vitrofluid platform (Specioso et al., 2022).
Optimizing Transgenic Animal Derivation Utilizing Sterile Hosts and a Sex-Specific Genetic Reporter
BACKGROUND Transgenic animals represent a powerful tool in Biology that enables the study of...

How to improve the breeding success of fragile dystrophic mice – comparison of 4 breeding schemes
Duchenne muscular dystrophy is a fatal genetic disorder affecting boys. Finding a cure relies on dystrophic mice. Dystrophic mice are notoriously difficult to breed and maintain using regular trios

A no-stress alternative to oral gavage in mice
The current method of oral gavage in mice using gavage needles is a source of stress for the animals, potentially misleading or invalidating the results of an experiment. There are currently minimal alternatives to this method.

Refining rodent i.v. injection training by creating, improving and disseminating realistic training models
Performing i.v. injections in rodents is a commonly needed task in research but challenging to learn in the beginning
3D-printed mouse tail models can be used to facilitate the learning process and reduce the number of practice
Standardising human organoid-based drug permeability assays
With the Modernization Act 2.0 signed in early 2023, the FDA paves the way for more new drug applications without animal testing. This decision puts researcher and drug developers back into the drivers seat to quickly bring non-animal-based pre-clinical studies to a level of trust, validation and broad acceptance by the public and regulatory authorities.
Multidimensional models for in vitro screening of endocrine disrupting agents
Endocrine disrupting chemicals (EDCs) are substances, both natural and human-made, present in everyday items like plastics, detergents, food, and cosmetics. These chemicals can adversely affect the health and development of both animals and humans. EDCs have been associated with disruptions in the endocrine system, contributing to conditions such as diabetes, cardiovascular disease, obesity, early puberty, infertility, and various cancers.

Refining estrous cycle through non-invasive collection procedures and deep learning classification
Recognizing the rodent estrous cycle as a crucial welfare indicator faces challenges due to a historical bias toward male animals in the scientific community.

Alone – together? – single housing of male mice
provide a strategy (cage connectors) to reduce the SD for single housed males from SD 3 to 1 by allowing visual, olfactory and acoustic contact between two IVCs

Refinement of anesthesia in neonatal mice
The choice of anesthesia for neonatal mice lacks a consensus and directly impacts animal welfare and research outcomes. The methods used until now to assess animal welfare do not provide a complete understanding of potential pain or discomfort experienced during anesthesia.

Scoresheet for Fish
With the refinement grant, we intend to develop, evaluate, implement, and publish score sheets for individuals and groups of fish. With the support of all fish labs of the University of Bern, the Experimental Animal Center (EAC) of the University of Bern, and the Institute for Laboratory Animal Science Zurich, we will (1) collect existing scoresheets from fish labs, but also from other experimental animal groups, (2) evaluate the scientific and grey literature on fish welfare assessment, and (3) retrieve information from fish facilities through visits and interviews on scorable indicators for fish welfare.

Minimizing the number of rodents used in the discovery of bacteriophage derived antimicrobials through candidate screening in zebrafish embryos
Antibiotic resistance poses a significant global health threat. A growing number of bacteria, such as multiple drug resistant (MDR) Pseudomonas aeruginosa and vancomycin resistant Enterococcus faecalis, cause life-threatening disease in humans, which cannot be treated efficiently. Bacteriophages, which are viruses infecting bacteria, and proteins derived from bacteriophages show promise as alternatives to antibiotics, demonstrating efficacy against antibiotic-resistant strains. Developing new antimicrobials typically involves testing in animal models, commonly mice.

A unique technology producing standardized lung cancer organoids in air/liquid interface conditions: a new alternative to animal experimentation
Lung cancer ranks among the most widespread cancers globally and is the leading cause of cancer-related deaths in Switzerland, with Non-Small Cell Lung Carcinoma (NSCLC) representing approximately 85% of cases. Researchers commonly rely on animal experiments to study NSCLC. Lung Cancer Organoids (LCO) derived from human biopsies offer a promising alternative to animal testing for research, personalized medicine, and drug screening.
Personal behavior profiles – tracking dogs for welfare monitoring
We optimize our kennels for videorecording so that we are capable of applying the latest in deep/machine learning based animal tracking/welfare monitoring techniques. We use behaviour flow analysis to build individual behaviour profiles for each of the dogs at baseline and monitor how they change in response to training and treatment

Application of non-surgical embryo transfer for the generation of transgenic models
Proposal for a more humane procedure for generating transgenic mouse and rat models. Current method involves invasive surgery, anesthesia, and potential post-operative pain. Suggests implementing non-surgical embryo transfer (NSET) for mice and rats, similar to human procedures
Implementation of a novel human ex-vivo skin culture technique to study the mechanism of action of therapeutics for inflammatory skin disease replacing animal testing
BACKGROUND Our group is developing ex-vivo models of human skin to investigate the mechanism of...

Ex-utero culture of mouse embryos
Our main aim is to expand the knowledge about mammalian brain development under physiological and teratogenic conditions. We consider that understanding how the balance between different kinds of progenitors is affected by teratogenic agents is of critical scientific interest. This knowledge will allow us to better interpret previous knowledge on the patterning of the brain and provide an example of the organizing principles of the dorsoventral axis at the cellular level.

Refined automated assessment of anhedonia, motivation and attention in mice
The behavioral assessment of anhedonia, motivation and attention represents a cornerstone of behavioral neuroscience, but is stressful and tedious for both, the involved animals and researchers. We will develop and promote protocols for assessing these behavioral paradigms fully automated in IntelliCage system. Thereby mice can voluntarily perform test sessions, while acting naturally in an undisturbed environment that also includes their normal social habitat.

Need and efficacy of pre-operative fasting in Sheep
Pre-operative fasting is a common procedure in veterinary medicine. It intends to reduce the filling of the stomach to avoid anesthetic complications. Sheep have a complex digestive system, recommendations of pre-operative fasting in this species are not evidence based. The practice can cause metabolic imbalances, complicating anesthesia
Modelling acquired drug resistance by high content imaging and multivariate analysis of patient-derived organoids
BACKGROUND Functional assessment of PNET biology has been hindered by the paucity of relevant...

iPSC-derived macrophages for a Lung-on-chip (LOC) model of bacterial colonisation
Current Lung on-chip (LOC) models are promising but lack resident immune cells especially macrophages. Our main project of Lung-Microbiota on-chip (LMOC) aims to (i) reduce animal experiments (short-term) and (ii) completely replace murine models of lung bacterial colonisation (long-term). The iPSC Macrophages will form an important component in this 3D human cell model.
Intraoperative nociception in animals: time to address and manage the issue efficaciously
During general anaesthesia, the brain does not perceive pain, but the spinal cord could still encode and elaborate the stimulus (nociception). Not recognising nociception is detrimental during general anaesthesia and can play a pivotal role in the development of post-operative and chronic pain. We propose the use of an objective method i.e. tracking of the nociceptive withdrawal thresholds as mean to evaluate nociception in animals undergoing general anaesthesia.
Human engineered heart models to investigate mechanisms of cardiac maturation
Since 2014, Marsano group has developed several functional healthy and disease (hibernate myocardium-like or scar-like) engineered 3D micro- and macro-scale cardiac tissues. Although neonatal cardiac cells were predominantly used to obtain proof-of-principles, the harness of human induced pluripotent stem cell-derived cardiomyocytes (iPSC-CM) is fundamental to investigate clinically relevant cardiac damage and repair mechanisms. My PhD projects would also immensely benefit the use of human iPSC-CM.
Molecular and Cellular characterization of developing Fragile X Synapses in human assembloids
Fragile X syndrome is a condition that affects the development of the nervous system. It is a leading cause of autism, a prevalent neurodevelopmental condition that is currently untreatable. Fragile X animal models display deficits at the level of neuronal connections called synapses. In addition, other cell types are affected including astrocytes. Astrocytes are glial cells important for proper neuronal connectivity and function.

Establishment and validation of a human in vitro model to investigate uptake transport at the Blood-Brain Barrier
The Blood-Brain Barrier is a structure between the central nervous system (CNS) and the bloodstream, whose main role is to protect the CNS from toxic compounds while allowing the passage of nutrients. Importantly, due to the activity of drug efflux transporters the Blood-Brain Barrier is seen as an obstacle for brain targeting drugs. This mechanistic understanding mostly relies on data from rodents, as it is difficult to measure and collect data on drug accumulation in the brain in humans.

Artificial intelligence-mediated drug synergy prediction and validation in patient-derived ex vivo tumor organoid models
In precision oncology, single drug treatment often leads to acquired resistance and tumor relapse. Novel drugs to overcome resistance are in development. Unfortunately, there is a substantial number of animals used, costs involved and high failure rates in the development of new drugs. Drug repurposing is increasingly becoming an attractive proposition because it involves ready to use compounds. Over the past decades we learned that the combination of multiple drugs can increase drug efficacy and reduce the development of drug resistance.

Cre-Rux – improving mouse well-being with a refined approach for in vivo genetic manipulation
Biomedical research relies on genetic manipulation of animals, particularly mice, as experimental models to mimic human diseases and study their mechanisms. A widely used system relies on the use of the enzyme Cre recombinase. A variant of this enzyme, CreERT2, needs the drug tamoxifen to be active. However, it is increasingly apparent that tamoxifen administration can be problematic. Reports show that tamoxifen administration can be toxic in mice.

Preventing the use of pregnant horses to produce PMSG by using immortalized chorionic girdle cells for the hormone production
Derived from the blood of pregnant horses, “pregnant mare serum gonadotropin (PMSG)”, is a hormone frequently used in farming and the breeding of mice and rats with specific genetic mutations. It is used in starting and synchronising the ovulation cyclies of of pigs, cattle and goats. In mice, the hormone is used to cause the release of an exceptional amount of egg cells at one time. It is currently isolated exclusively from live pregnant horses, and it has been reported that from these pregnant “production” mares up to 10 litres of blood are taken weekly until around 4 months of pregnancy.

3D-printed mouse tail models for intravenous injection training
To perform i.v. injections on mice reliably, extensive training is required. This is usually performed on live animals.
For the first steps of training (handling of syringes and the tail), our 3D-printed mouse tail models can be useful placeholders instead of using live animals. Conception, prototyping and first testing of 3D-printed mouse tail models is already accomplished. Tail models should be manufactured in larger quantities and distributed among researchers / trainers. Detailed user experience data should be collected to optimize the tail models and confirm their usefulness. Publishing this data should increase acceptance and use of the tail models.

Automation, Optimisation and Dissemination of the Mouse Grimace Scale
We will develop, refine, and optimize a new setup that will enable labs all over the world to use the mouse grimace scale to accurately, easily and reliably assess pain in rodents. We will apply cutting-edge machine vision/learning technology to ensure the data collected is of the highest quality. We will collaborate with other labs to directly test the ease of use and transferability of the new setup and aim to increase the reliability and reproducibility of animal welfare monitoring in rodents worldwide

Best practice guidance for including sex as a biological variable in animal research
In animal research, a strong bias towards using male animals is apparent in most disciplines. By using animals of only one sex, researchers risk missing important sex differences and using animals for inconclusive findings. In response to such overt sex bias, major funders now request inclusion of sex as a biological variable in all animal experiments. However, this poses challenges to the 3Rs: experiments may require up to twice as many animals and researchers face difficult logistical decisions with important implications for both animal welfare and scientific validity.

Experimental toolkit to evaluate cell-based therapies in the mouse brain
For every 100 prospective therapies in clinical development, approximately 90 are never approved for clinical use. This unsatisfactory rate is especially high in the field of neurosciences, revealing the complex biology of the human brain and the necessity for improved preclinical validation of experimental treatments. Recent advances in stem cell biology and genetic engineering have caused cell therapies to become an emerging treatment paradigm for patients with permanent neurologic deficits (e.g. after a stroke).
Refining intracerebral administration of drugs with sonoporation-activated microbubbles
Intracerebral administration of central nervous system (CNS) active agents through intracranial surgery is a widely used procedure in modern neuroscience. The discovery of new therapeutic treatment options for CNS diseases or the use of viruses to study the molecular and cellular functions of a gene within an identified cell type in the brain, mainly explain why such a methodology is popular among neuroscientists. Indeed, the range of molecules entering the brain parenchyma is greatly limited by the blood-brain barrier (BBB).

Identifying new regulators of cell invasion in colorectal cancer using the Drosophila adult intestine
Colorectal cancer (CRC) is a cancer of the colon and the rectum. It is the third most prevalent cancer worldwide and is the fourth most common cause of cancer-related deaths. If the cancer is localized, the five-year survival rate is 90%; if the cancer has spread – metastasized – the five-year survival rate drops to 14%. Consequently, it is crucial to understand how CRC cells adopt a metastatic fate.

Reducing the need for lethal health monitoring in trout
Proliferative Kidney Disease (PKD) is a deadly parasitic fish disease that is classified as reportable and that has to be monitored in Switzerland. For this purpose, 15’500 potentially healthy pre-reproductive brown trout were electrofished and euthanized since 2000 to determine their PKD status by the applicant at the Centre for Fish and Wildlife Health (FIWI) alone.

Engineering a novel cell-based model for assessing materno-fetal drug transfer during pregnancy
The human placenta is a vital organ that acts as a barrier between the circulation of the mother and the growing fetus. It represents the interface between specialized placental cells called trophoblasts and fetal endothelial cells of the micro-vessels. Together these two tightly polarized cell layers perform crucial functions such as nutrient transport to the fetus or production of hormones.

Development of a platform for GU cancer patient-derived organoids
Understanding and overcoming cancer therapy resistance is a major overarching goal of our precision oncology program at the University of Bern. One of the greatest hurdles is the lack of reliable model systems to untangle resistance on a patient to patient basis. Animal models have been widely used to test highly focused questions in oncology and tumor resistance. However, to answer specific questions on a patient-specific basis animal models are not ideal, mostly because experiments are time consuming and incompatible with high-throughput screening.

IPF-on-Chip: Replacing the bleomycin induced lung injury and fibrosis model with lung-on-chip technology
Today, new antifibrotic drugs for idiopathic pulmonary fibrosis (IPF) are tested in mice with the bleomycin-induced lung-injury and lung fibrosis model. Nevertheless, the resulting fibrotic lung of rodents is different from the fibrotic lung of IPF patients. Therefore, many drug candidates successful in the bleomycin model often fail in later clinical trials. The reasons for this are interspecies differences and difference between IPF, which is slow and irreversible in humans compared to the sharp and acute effect of the bleomycin injury to the mouse lung.

BEHAVE: A toolkit for deep-behavior profiling of laboratory rodents
Many hundred-thousand rodents, mostly mice, are used in behavioural neuroscience research every year. This is necessary, because behaviour is the ultimate readout for brain function in health and disease, and developing treatments for brain disorders requires proof that behavioural disturbances can be corrected.

Nutritional requirements of fish cell lines – development of a serum-free culture medium (L-15Plus)
Manmade chemicals have become an essential commodity in our daily lives, from personal care to medicine and agriculture. Regulators require companies to conduct safety testing because, despite their benefits, such chemicals may also pose risks to human and environmental health. Environmental risk assessments still heavily rely on tests with fish. To replace such fish tests, we are developing strategies and assay procedures based on permanent fish cell lines of rainbow trout (Oncorhynchus mykiss), a key species for environmental protection.

Rodents have a right to best surgical practice
Surgery is an integral part of many experimental animal studies. Anaesthesia and analgesia protocols are obvious targets for refinement. Good surgical practice, however, is often neglected. Performing surgery fast, minimally invasive and with optimal peri-and post-operative care helps reduce animal suffering, enables faster recovery with fewer complications and improves the reproducibility of study results.

Recombinant laminin-like proteins for organoid cultures free of animal-derived basement membrane extract
Organoids are miniature organs generated from stem cells that provide unique in vitro models of organs in health and disease, and hold promises for personalized medicine and tissue engineering. They alleviate the need for animal experiments, as they enable the study of biomedical questions directly in vitro. They have become a cornerstone of 21st century biomedical research, and they still constitute a fast-developing field. In many cases, the tissue responsible for the organ-specific function – the parenchyma – is an epithelium, supported by a specialized matrix called a basement membrane.

Breeding management software for genetically modified rodents
Scientists frequently use genetically modified animals in basic and applied research. They often combine multiple genetic modifications requiring complex breeding schemes. Some of the surplus animals that do not carry the required traits cannot be used for research or further breeding and are usually euthanized. Such supernumerary animals cannot be entirely prevented, but their numbers must be kept to the minimum possible. Therefore, we aim to optimise breeding strategies for complex genetic models, which is not possible manually.

3D heart models for cardiac surgery training
Surgery training on live animals is a controversial subject. While prohibited in Switzerland, surgical training on live animals is performed in many other countries. Several scientific publications as well as organisers of workshops open to a large audience of surgeons support this practice. Our goal is to develop a realistic and cost-effective alternative to the use of live animals for cardiovascular training.

A CRISPR/Cas9-screening platform to decipher conserved cell fate specification networks in vivo
All human cell types originate from a single fertilized egg. Understanding how these diverse cells emerge during development can help scientists recreate specific cell types in the lab for use in medicine, such as tissue repair and regeneration.

Mice refinement: from invasive intratracheal instillation to intubation for lung fibrosis studies
We want to learn the intubation technique to refine the current intratracheal instillation surgery technique. Intubation is used in several rodent models, to study lung physiological and pathological models. Intubation has been is along-established technique extensively performed in rats.

Swiss 3RCC and the 3Rs and the Pint of Science Switzerland
The Pint of Science has had huge success in reaching the public with science for many years and we were delighted to host evenings of the 3Rs presentations and discussion in Bern and Geneva in May 2025.

3Rs Innovation Challenge
Join us to innovate and co-create 3Rs projects with expert facilitators.

Kristin Schirmer & Melanie Fischer
In 2019, the 3RCC awarded Kristin Schirmer and Melanie Fischer from Eawag for their outstanding...

Using organoids to move towards personalised medicine
Dr. Yazici’s research focuses on developing organoids (lab grown tissue that mimics specific organs in structure and function) derived from human stem cells. Stem cells are cells that have the unique ability to develop into various specialised cell types.

PUBLICATION: Replacing Animal Testing: How and When?
An important discussion in today’s society is whether we should make animals suffer for the sake...

Forum on behavioral research in laboratory animals
www.TheBehaviourForum.org is an online forum for discussion of animal behaviour experiments....

3Rs at the Pint of Science
The Pint of Science has had huge success in reaching the public with science for many years and we were delighted to host evenings of the 3Rs presentations and discussion in Bern and Geneva in May 2025.

3Rs SUPPORT GRANT
Supporting ongoing research activities relevant to the 3Rs. Increasing 3Rs implementation, education and/or communication. Grants here are generally expected to be maximum CHF 20’000.- and as such function to enhance or implement 3Rs activities. This scheme replaces the previous Refinement Grant, without the strict focus and potential 3Rs-classification issues we’ve encountered. Next call likely to be 2026, or late 2025.
Dr. Homare Yamahachi is appointed as new Executive Board Chair
The Swiss 3R Competence Centre (3RCC) has appointed former Vice Chair, Dr. Homare Yamahachi from the University of Bern as the new Executive Board Chair, effective 2025.

NON-ANIMAL APPROACHES ACROSS EUROPE: High fidelity computational approaches to model cardiovascular diseases
This webinar series from The Togeth3R Consortium of European 3Rs centres showcases advances in model development and opportunities to apply non-animal approaches in research fields associated with high levels of animal use.

NON-ANIMAL APPROACHES ACROSS EUROPE: Human stem cell-derived cardiomyocytes for cardiotoxicity screens
This webinar series from The Togeth3R Consortium of European 3Rs centres showcases advances in model development and opportunities to apply non-animal approaches in research fields associated with high levels of animal use.

NON-ANIMAL APPROACHES ACROSS EUROPE: Advanced heart-on-a-chip models in disease modelling and drug screening
This webinar series from The Togeth3R Consortium of European 3Rs centres showcases advances in model development and opportunities to apply non-animal approaches in research fields associated with high levels of animal use.

NON-ANIMAL APPROACHES ACROSS EUROPE: BRAINCELL, a computational platform to explore in silico realistic 3D brain cells and their interactions
This webinar series from The Togeth3R Consortium of European 3Rs centres showcases advances in model development and opportunities to apply non-animal approaches in research fields associated with high levels of animal use.

NON-ANIMAL APPROACHES ACROSS EUROPE: Human neuronal models of Alzheimer’s disease for understanding disease mechanisms and developing novel therapies
This webinar series from The Togeth3R Consortium of European 3Rs centres showcases advances in model development and opportunities to apply non-animal approaches in research fields associated with high levels of animal use.

NON-ANIMAL APPROACHES ACROSS EUROPE: Brain organoids to study Alzheimer’s disease – A comparative approach
This webinar series from The Togeth3R Consortium of European 3Rs centres showcases advances in model development and opportunities to apply non-animal approaches in research fields associated with high levels of animal use.

NON-ANIMAL APPROACHES ACROSS EUROPE: Tissue-on-chip models using patient biopsies to study patient response
This webinar series from The Togeth3R Consortium of European 3Rs centres showcases advances in model development and opportunities to apply non-animal approaches in research fields associated with high levels of animal use.

NON-ANIMAL APPROACHES ACROSS EUROPE: Patient-derived leukaemia organoids
This webinar series from The Togeth3R Consortium of European 3Rs centres showcases advances in model development and opportunities to apply non-animal approaches in research fields associated with high levels of animal use.

NON-ANIMAL APPROACHES ACROSS EUROPE: AirLiwell technology – Development and perspectives in oncology replacement
This webinar series from The Togeth3R Consortium of European 3Rs centres showcases advances in model development and opportunities to apply non-animal approaches in research fields associated with high levels of animal use.

NON-ANIMAL APPROACHES ACROSS EUROPE: Building a virtual twin of the rheumatic joint
This webinar series from The Togeth3R Consortium of European 3Rs centres showcases advances in model development and opportunities to apply non-animal approaches in research fields associated with high levels of animal use.

NON-ANIMAL APPROACHES ACROSS EUROPE: Infection, innate immune signalling and cancer in the gut – Organoids as models
This webinar series from The Togeth3R Consortium of European 3Rs centres showcases advances in model development and opportunities to apply non-animal approaches in research fields associated with high levels of animal use.

NON-ANIMAL APPROACHES ACROSS EUROPE: A cross-species ex vivo assay for tuberculosis vaccine testing
This webinar series from The Togeth3R Consortium of European 3Rs centres showcases advances in model development and opportunities to apply non-animal approaches in research fields associated with high levels of animal use.

Targeted Call 2023
Advancing responsibility: Reducing Surplus Animals and Promoting Change

Animal Use in Swiss Science: A look at Severity
To improve animal welfare in Switzerland, we need to understand not only how many animals and which species are used but also how they are used. By analysing 27 years of publicly available data, this report examines trends in the number of animal uses and their severity classification.

Dr. Petra Seebeck & Dr. Stephan Zeiter – 2024 Culture of Care Award
Awarded for their pioneering initiative in promoting Good Surgical Practice in rodent surgery.
Nominations for the 3Rs Awards open on February 1st
The main 3Rs Award of CHF 4’000.- is given for exceptional work that has made a significant contribution to the Replacement, Reduction, and Refinement of animal experimentation (the 3Rs Principle).
A further CHF 2500.- prize, the Young 3Rs Investigator Award, is given to two researchers in the early stages of their careers for their individual achievements advancing the 3Rs principle and is co-funded by the NRP 79.

Open Funding Opportunities
Swiss 3RCC Funding Opportunities: Now Accepting Applications
Swiss 3RCC is pleased to announce its funding schemes for the 2025–2028 period. These grants aim to advance the principles of the 3Rs (Replacement, Reduction, Refinement) through innovative research.
Culture of Care Award 2024
The award goes to Dr. Petra Seebeck (University of Zurich) & Dr. Stephan Zeiter (AO Research Institute Davos) for their pioneering initiative in promoting Good Surgical Practice in rodent surgery.
The 3Rs meet Improvised Theatre!
The 3Rs are a fundamental principle for professionals working in science with animals, yet outside the research community, they remain relatively unknown. For the 3RCC, outreach is imperative—not only to highlight the importance of animals in research but also to showcase the continuous progress being made to Replace and Reduce animals in science, and to Refine their use. With this goal in mind, and on a chilly Saturday night in November, the 3RCC brought the 3Rs to a packed audience at CatCave9, a monthly improv show.

REPLACEMENT IN ONCOLOGY RESEARCH: Use of 3D co-culture spheroids as a model to search for antiproliferative compounds
Dr Muriel Cuendet from the School of pharmaceutical sciences at the University of Geneva, Switzerland, presents her work on the use of 3D co-culture spheroids as a model to search for antiproliferative compounds against multiple myeloma.

REPLACEMENT IN ONCOLOGY RESEARCH: AI-mediated drug synergy prediction and validation in tumor organoid models
Alicia Pliego Mendieta from the Laboratory for Systems Pathology and Functional Tumor Pathology at the University of Zurich, Switzerland, presents her work on AI-Predict: an artificial intelligence-mediated drug synergy prediction and validation strategy in patient-derived tumor organoid models.

REPLACEMENT IN ONCOLOGY RESEARCH: The progression of methods in cancer research
Dr Marianna Kruithof-de Julio from the Department for BioMedical Research at the University of Bern, Switzerland, presents an overview on the progression of methods in cancer research.

REPLACEMENT IN ONCOLOGY RESEARCH: New approach methodologies for personalized colorectal cancer treatment
Dr George Ramzy from the Department of cell physiology and metabolism at the University of Geneva, Switzerland, presents his work on new approach methodologies for personalized colorectal cancer treatment.

REPLACEMENT IN ONCOLOGY RESEARCH: The AirLiwell technology to produce organoids in air/liquid interface
Dr Olivier Preynat-Seauve from the Department of Medicine at the University of Geneva, Switzerland, presents his work on the AirLiwell technology to produce standardized organoids in air/liquid interface conditions.

REPLACEMENT IN ONCOLOGY RESEARCH: Systems pharmacology: identify therapeutic targets and personalize drug combinations
Dr Annabelle Ballesta from the Institut Curie in Paris, France, presents her work on systems pharmacology to identify therapeutic targets and personalize drug combinations.

Dr. Duygu Yazici – Young 3Rs Investigator 2023
Duygu Yazici has received the Young 3Rs Investigator Award for creating advanced lab models that mimic human organs using stem cell technology and organ-on-a-chip devices.

Viola Bugada – Young 3Rs Investigator 2023
Viola Bugada (Institute of Experimental Immunology, UZH) receives the Young 3Rs Investigator Award for her contribution to refining oral drug administration to rodents.

Prof. Benjamin Ineichen, STRIDE-Lab – 3Rs Award 2023
The 3Rs Award 2023 goes to the STRIDE-Lab led by Benjamin Ineichen, Research group leader, Center for Reproducible Science, UZH) for its exceptional contributions to animal welfare in research.
Results of 2023 Targeted Call
Two pioneering research projects will be funded under the Targeted Call 2023 funding scheme to advance responsibility by reducing surplus animals and promoting change.
3Rs Awards 2023
The Swiss 3RCC has announced the recipients of the 2023 3Rs award and the Young 3Rs Investigator Award.

TUMOR MONITORING: Challenges in enabling translation of tumor models in cancer therapy
Christian Schnell’s (Novartis Oncology) talk on “Challenges in enabling translation of tumor models in cancer therapy: Exploiting secreted luciferases to monitor tumor metastasis as a promising approach” at the Swiss 3Rs Day 2024 in the AGORA Cancer Research Centre in Lausanne.

AVOIDANCE OF SURPLUS: Breeding of Genetically Engineered Mouse Models
Dr Daniel Breustedt and Filippo Gallegra from Novartis Pharma AG present their work on Breeding of Genetically Engineered Mouse Models – Challenges, Opportunities and Lessons Learned.

AVOIDANCE OF SURPLUS: Managing Genetically Engineered Animals Through the Lens of the 4Rs
Dr Jean Cozzi of the company Charles River Laboratories, presents his work on Managing Genetically Engineered Animals Through the Lens of the 4Rs.

Annual Report 2023
The Swiss 3Rs Competence Centre (3RCC) continues to drive progress in the implementation of the...

Animal Caretaker Team University of Basel – 2023 Culture of Care
The Animal Caretaker Team from the Department of Biomedicine, University of Basel has exhibited an exemplary approach to sustainably reduce surplus animals.
Results of 2022 Targeted Call
The 3RCC will fund five research projects spanning different focuses within the 3Rs (replacement, reduction, refinement) at Swiss research institutions with a total of CHF 1,855,623.
New Vice President Prof. Dr. Rolf Zeller
The Swiss 3R Competence Centre (3RCC) is pleased to announce the appointment of Rolf Zeller as its new Vice President.

ZEBRAFISH REFINEMENT: The EggSorter, an automated tool to standardize the processing of zebrafish embryos
Ana Hernando Ariza from Bionomous SA presents her work on the EggSorter : an automated tool to standardise the screening, sorting, and dispensing of zebrafish embryos.

ZEBRAFISH REFINEMENT: Refinement of zebrafish husbandry
Dr Colette vom Berg from the EAWAG, Switzerland, presents her work on the refinement of zebrafish husbandry.

ZEBRAFISH REFINEMENT: Skin swabbing as a refined technique to collect DNA samples from laboratory fish
Dr Will Norton from the University of Leicester, United Kingdom, presents his work on skin swabbing as a refined technique to collect DNA samples from laboratory fish.

ZEBRAFISH REFINEMENT: Implementing enrichment for laboratory zebrafish
Dr Chloe Stevens from the RSPCA, United Kingdom, presents her work on implementing enrichment for laboratory zebrafish.

ZEBRAFISH REFINEMENT: Pain assessment, anaesthesia and analgesia in zebrafish
Dr Lynne Sneddon from the University of Gothenburg, Sweden, presents her work on pain assessment, anaesthesia and analgesia in zebrafish.

ZEBRAFISH REFINEMENT:Culture of care in zebrafish
Dr Andrina Zbinden from the University of Fribourg, Switzerland, presents her work on the Culture of Care in zebrafish.

Dr. Wei Wei – Young 3Rs Investigator 2022
The 3Rs Young Investigators Award 2022 goes to Wei Wei from ETH Zürich for his work on creating a three-dimensional model of the brain’s protective wall, the blood-brain-barrier.

Prof. Guillaume Andrey – 2022 3Rs Award
The 3Rs Award 2022 goes to Prof. Guillaume Andrey from the University of Geneva for his work to reduce the use of transgenic animals in developmental studies.

Dr. Julie Parchet-Piccand – 2022 Culture of Care Award
The 2022 and inaugural CoC award goes Dr. Julie Parchet-Piccand for her project on improving the knowledge of experimental licenses and research projects for animal caretakers.

Annual Report 2022
This report highlights the remarkable progress made by the Centre in the past year towards its...

Multicenter Survey on Tunnel Handling
This project gathered data from semi-structured interviews to four animal facility managers with some pilot experience on tunnel handling within their facilities, and from 20 animal caretakers who have experienced tunnel handling.

TUNNEL HANDLING: Introduction and practical advice
This video is a lay introduction by Prof. Paulin Jirkof from the University of Zürich to Tunnel Handling, a non-aversive way to handle laboratory animals developed by Prof. Jane Hurst from the University of Liverpool.

Pauline Zamprogno – 2021 Young 3Rs Investigator Award
The 2021 3Rs Young Investigator Award goes to Pauline Zamprogno from the ARTORG for her contribution to a lung-on-chip model.

Bernhard Voelkl – 2021 3Rs Award
The 2021 3Rs Award goes to Bernhard Voelkl from the Vetsuisse Faculty of the University of Bern for his work improving better design of animal studies.

Annual Report 2021
2021 was an important year for the 3RCC as it was the first of a new funding period stretching to...

BASEMENT MEMBRANE EXTRACT: The future of BMEs and their replacements – Panel discussion
A chance for previous speakers to come together to discuss the wider topic of replacing BMEs, and the 3Rs implications of the approaches discussed.

BASEMENT MEMBRANE EXTRACT: BMEs and replacements for clinical application areas
Touching on diagnostics, regenerative medicine and the regulatory aspects of replacing BMEs.

BASEMENT MEMBRANE EXTRACT: BMEs and replacements from a research perspective
Exploring different applicational areas, from basic research to preclinical drug development where BMEs can be replaced, and how the replacements can be incorporated into translational research.

BASEMENT MEMBRANE EXTRACT: Replacing basement membrane extracts – Introduction
What are BMEs, and what are the challenges that come with replacing them? What are the hurdles and opportunities that BMEs present across different application areas?

Bachelor Courses on 3Rs Education
The 3RCC surveyed the institutions to map existing courses on 3Rs or containing 3Rs information.

Animal Use in Swiss Education
A Perspective from Swiss HEIs in 2018

Joseph Scarborough – 2020 Young 3Rs Investigator Award
The Young 3Rs Investigator Award 2020 will go to Joseph Scarborough for his work in Prof. Urs Meyer’s laboratory at the Institute of Veterinary Pharmacology and Toxicology at the University of Zurich.

Ronald Dijkman – 2020 3Rs Award
The 3Rs Award 2020 will go to Ronald Dijkman at the Institute for Infectious Diseases of the University of Bern.

Animals in Swiss Science
A breakdown and analysis of expired animal experimentation licenses in Switzerland

Non-Aversive Handling Survey
Mice have been, and remain the most commonly used animal in scientific research in most of the world, including in Switzerland (according to both the annual statistics on animal use in Switzerland, and the Swiss 3RCC’s own report on animal use in experimentation). Not counted in those statistics is the number of mice which are only included in breeding programs, or simply do not take part in a licensed animal experimentation for other reasons.

Annual Report 2018-2020
The Swiss education and research landscape is complex and multifaceted, as is the implementation...

Kristin Schirmer & Melanie Fischer – 2019 3Rs Award
For 2019, the 3RCC awards Kristin Schirmer and Melanie Fischer from Eawag for their outstanding research work in the 3Rs area of replacement.